Amy K. Poshusta

Amy Poshusta, PhD joined Olatec’s Drug Development Team in December 2012 and became a member of the Scientific Advisory Board in December 2019. Dr. Poshusta is Olatec’s liaison to FDA and relevant European regional regulatory bodies. Dr. Poshusta has lead responsibility for all submissions to regulatory agencies as well as compliance requirements of the Company’s open regulatory applications, e.g., IND’s and IMPDs. Dr. Poshusta has over 15 years of pharmaceutical experience and involvement in all aspects of pharmaceutical development including clinical, nonclinical, and Chemistry, Manufacturing and Controls (CMC), for the major regulatory markets including the USA, EU, Australia and Canada. Her pharmaceutical experience encompasses proprietary drugs and new indications and/or dosage forms for existing drugs. Dr. Poshusta received her BA degree in Mathematics/Physics from Whitman College and her MS and PhD in Chemical Engineering from the University of Colorado at Boulder.